Ovarian androgens
(follicular endocrine function)

Ovarian androgens are an essential physiological component of female endocrine function and, under normal conditions, do not represent merely residual products of steroidogenesis or signals exclusively associated with disease. Within the ovary, molecules such as androstenedione and testosterone participate directly in follicular biology, act as obligatory precursors for estrogen synthesis and contribute to the regulation of follicular growth, gonadotropin sensitivity and the functional competence of granulosa and theca cells. Their physiological significance therefore depends not only on the amount produced, but also on the follicular context in which they are generated, used, converted or inactivated.

Ovarian androgen physiology is one of the clearest examples of integration among steroidogenesis, cellular cooperation and local regulation of endocrine signaling. Synthesis requires cholesterol availability, enzymatic activation of the steroidogenic pathway within the theca interna, regulation by LH and paracrine communication with granulosa cells, which use androgens as substrates for estrogen aromatization. Systemic and tissue metabolism includes interconversions between precursors and active hormones, binding to plasma proteins, peripheral inactivation and, within certain tissues, conversion into compounds with greater or lower androgenic activity. Biological action occurs mainly through the androgen receptor, with transcriptional and non genomic effects that modulate follicular development and integration of the hypothalamic pituitary ovarian axis. This page analyzes ovarian androgens along their entire functional pathway, from biosynthesis to tissue specific regulation of their actions.

The ovarian androgen system follows a physiological logic that differs from that of estrogen and progesterone signaling. Androgens produced within the ovary are not merely final effectors, but also strategic intermediates in follicular steroidogenesis. In particular, androstenedione and testosterone are the substrates required by granulosa cells to produce estradiol through aromatization. This means that part of ovarian androgen function consists of enabling estrogen signaling, placing androgens upstream as an essential step in its production.

However, the significance of androgens is not limited to their role as precursors. At physiological concentrations, they participate in the regulation of folliculogenesis, modulate the proliferation and differentiation of granulosa cells, influence FSH receptor expression and contribute to defining the endocrine competence of the growing follicle. Ovarian androgen signaling therefore has a permissive and modulatory function. It does not replace estrogens in directing the follicular phase, but enables their full expression and contributes to organizing their biological efficiency.

From an endocrinological perspective, androgen action within the ovary is therefore dose dependent and context dependent. Physiological androgen levels support follicular development and steroidogenesis, whereas excess levels, particularly when persistent, may impair follicular maturation, compromise selection of the dominant follicle and disrupt axis integration. This dual nature explains why androgens must be interpreted as necessary hormones whose concentrations must remain within a tightly regulated range.

Three principles explain why ovarian androgens are physiologically indispensable but must remain tightly regulated:

• obligatory precursors for estrogen synthesis within granulosa cells;
• follicular modulators of growth, FSH sensitivity and endocrine competence;
• biphasic signaling with beneficial effects at physiological levels and dysfunctional effects during persistent excess.

This conceptual framework explains why understanding androgen physiology must begin with biosynthesis in the theca. The way in which the follicle generates androstenedione and testosterone, and the way in which these compounds are transferred, converted or used locally, determines the entire steroidogenic balance of the ovarian compartment.

Ovarian androgen synthesis begins with cholesterol, the common precursor of gonadal steroids. As in other steroidogenic tissues, the transfer of cholesterol to the inner mitochondrial compartment represents an essential regulatory step and depends on intracellular systems that make the substrate available to the biosynthetic pathway. Conversion of cholesterol into pregnenolone initiates a sequence of reactions that, within the ovarian compartment, leads to the formation of the principal androgen precursors.

The main site of androgen biosynthesis within the follicle is the theca interna, which responds primarily to LH stimulation. Theca cells express the enzymes required for the production of androstenedione and testosterone, including CYP17A1, an enzyme with 17α hydroxylase and 17,20 lyase activity that is crucial for directing steroidogenesis toward androgen formation. This enzymatic profile distinguishes theca cells from granulosa cells and explains the functional specialization of the different cellular compartments within the follicle.

Ovarian androgen synthesis forms part of the classic two cell, two gonadotropin model. LH stimulates theca cells to produce androgens, while FSH acts on granulosa cells and promotes aromatization of these androgens into estrogens. This means that androgen signaling cannot be interpreted separately from estrogen physiology. It constitutes its obligatory preliminary step and represents the specific contribution of the thecal compartment to overall follicular biology.

Androgens produced within the theca diffuse across the basal lamina and reach granulosa cells, where they can be converted into estrogens or exert direct biological effects through the androgen receptor. In this way, the follicle does not use androgens solely as substrates to be removed through aromatization, but also as genuine local signals capable of modulating the growth and function of its cellular components.

Androgen biosynthesis does not depend solely on central gonadotropic regulation. Intraovarian paracrine signals, growth factors, metabolic status and the quality of communication among theca cells, granulosa cells and the oocyte influence the expression of steroidogenic enzymes and the amount of androgens produced. This clarifies that ovarian androgen secretion reflects not only LH activation, but also the overall functional state of the follicular microenvironment.

From a physiological perspective, androstenedione production generally predominates quantitatively, whereas the amount of testosterone depends on subsequent enzymatic conversions within the different compartments. This biosynthetic hierarchy is relevant because it demonstrates that ovarian androgen signaling does not correspond to a single molecule, but to a network of precursors and products that may be further converted into estrogens or into other active or inactive androgen metabolites.

The ovary contributes physiologically to the circulating pool of female androgens, but the primary significance of its secretion is local. Androgens produced within the theca primarily supply the follicular unit, and only a proportion reaches the systemic circulation. Ovarian androgen function must therefore be understood not only as plasma secretion, but as a steroidogenic microenvironment that supports follicular maturation and estrogen production.

During follicular growth, androgen availability must be adequate but not excessive. Within follicles undergoing selection, physiological androgen levels enhance the response to FSH, promote granulosa cell proliferation and support the efficiency of aromatization. This state allows the dominant follicle to acquire increasing endocrine competence. Conversely, when androgen signaling exceeds the capacity of granulosa cells to use and convert it, follicular balance may be impaired.

Ovarian androgen secretion therefore varies according to the functional state of the theca, LH sensitivity and the quality of communication between theca and granulosa cells. It is not merely a constant background production, but a dynamic process that reflects the number and quality of active antral follicles, the degree of thecal steroidogenesis and the balance between androgen synthesis and estrogen conversion.

This principle has an important corollary: the systemic androgen concentration does not always accurately describe androgen exposure within an individual follicle. A follicle may be locally exposed to significant androgen signaling even in the absence of marked serum abnormalities, because ovarian physiology is strongly compartmentalized and depends on local gradients of production, diffusion and utilization of steroid precursors.

The distribution of androstenedione, testosterone and other precursors also determines the type of signal available to tissues. Some molecules function mainly as intermediates, while others have greater direct receptor activity. Understanding this balance therefore requires consideration of plasma transport and the bioavailability of the different androgens, because the free fraction and the possibility of peripheral conversion influence the overall action of the system.

In the blood, androgens circulate largely bound to plasma proteins, particularly SHBG and albumin. Protein binding performs a crucial physiological function. It stabilizes the signal, creates a circulating reservoir and limits rapid fluctuations in the biologically available fraction. The free fraction is quantitatively small, but represents the proportion that can more readily enter tissues and interact with the androgen receptor or local enzymatic systems.

SHBG is particularly relevant because it markedly influences the bioavailability of testosterone and other sex steroids. Variations in its concentration can alter the relationship between total levels and the free fraction, explaining why measurement of total hormone alone does not always adequately describe the intensity of tissue androgen exposure. This also applies to ovarian physiology, in which local signaling may be further modulated by the systemic availability of free forms.

From an endocrine perspective, plasma transport connects the ovarian compartment with systemic metabolism. A proportion of the androgens produced by the ovary reaches peripheral tissues, where they may be converted, inactivated or used as substrates for further steroid transformations. The circulation therefore serves not only to distribute the hormone, but also to integrate it with the liver, adipose tissue, skin, muscle and other tissues that possess steroidogenic or metabolizing enzymes.

Differences in binding among androstenedione, testosterone and other precursors also contribute to the distinct biological kinetics of the individual molecules. Some forms have greater systemic persistence, whereas others depend more closely on continuous production or peripheral conversion. These properties are relevant because they demonstrate that female androgen signaling is not a uniform entity, but a dynamic balance among molecules with different protein binding affinities, receptor potencies and metabolic fates.

Plasma transport, however, does not by itself determine biological action. Androgens must be converted, activated or inactivated within tissues and, in certain contexts, used as precursors for estrogen synthesis. To understand the complete organization of the system, it is therefore essential to describe ovarian androgen metabolism and the relationship among conversion, follicular utilization and peripheral elimination.

Androgen metabolism represents one of the central nodes of their physiology because it determines whether the signal will be used as a substrate for estrogens, retained as an active androgen or directed toward inactivation. Within the ovary, the most relevant metabolic fate is aromatization within granulosa cells, which converts androstenedione and testosterone into estrone and estradiol. This step directly links androgen signaling to estrogen production and explains why the balance between theca and granulosa cells is essential for follicular homeostasis.

Androgens may also undergo local and peripheral interconversions. Androstenedione can be converted into testosterone and vice versa through enzymatic systems that modulate the receptor potency of the signal. In addition, within certain tissues, testosterone may be converted into compounds with greater androgenic activity through 5α reduction. Although this pathway is not the principal fate within the physiological follicle, it demonstrates that androgen signaling can be amplified or attenuated according to the enzymatic profile of the tissue.

Peripheral metabolism also includes hepatic inactivation processes, followed by conjugation and biliary or urinary elimination. These mechanisms contribute to systemic clearance and stability of the circulating signal. From an endocrine perspective, however, the most relevant point remains that androgen fate is strongly context dependent. The same molecule may become an estrogen, act directly on the androgen receptor or be inactivated, depending on the cellular compartment in which it is located.

This metabolic flexibility makes androgens a regulatory system rather than merely an end product of the steroid pathway. Within the ovary, in particular, the relationship between thecal production and granulosa cell aromatase capacity determines whether the follicle will use androgens to support growth and estrogen synthesis or accumulate an excessive and potentially dysfunctional androgen signal. Androgen physiology is therefore inseparable from the ability of the follicle to metabolize its precursors correctly.

Metabolism also integrates with the function of extraovarian tissues, which can use circulating androgen precursors for further transformations. This means that the biology of ovarian androgens does not end within the follicle, but continues within a systemic network involving the liver, adipose tissue and other tissues capable of modulating the final bioavailability of the signal.

The classical action of androgens is mediated by the androgen receptor (AR), a member of the nuclear receptor superfamily. Within the ovary, AR is expressed in different compartments, including granulosa cells, theca cells and, during certain stages and in certain species, other components of the follicular unit. The presence of this receptor confirms that androgens do not function solely as estrogen precursors, but act as genuine local regulators of follicular biology.

After ligand binding, the androgen receptor undergoes a conformational change, translocates to the nucleus, dimerizes and interacts with regulatory DNA sequences, recruiting coactivators or corepressors that modulate gene transcription. The final result depends not only on hormone concentration, but also on receptor density, the epigenetic context and the composition of the coregulators present within the target cell.

Within the follicle, genomic androgen action can promote granulosa cell growth, enhance the response to FSH, support the expression of steroidogenic enzymes and contribute to maturation of the follicular compartment during the early and intermediate stages of growth. This explains why physiological androgen signaling is considered permissive or supportive of normal folliculogenesis. The follicle develops not despite androgens, but partly because of their adequate and controlled presence.

The same principle also explains the vulnerability of the system to androgen excess. When receptor activation exceeds the physiological window, the transcriptional response may alter the balance among proliferation, differentiation and aromatization, disrupting follicular selection and promoting dysfunctional states. The androgen receptor is therefore a biological precision mechanism, necessary for normal follicular function but potentially disruptive when signaling becomes quantitatively or temporally inappropriate.

The tissue specificity of androgen action also depends on interaction with other endocrine signals, particularly estrogens, insulin, IGF and gonadotropins. The follicle interprets androgens within an integrated signaling network, not as an isolated message. This concept is fundamental for understanding why ovarian androgen action is so closely linked to the overall quality of the follicular microenvironment.

Alongside classical nuclear action, androgens can activate rapid non genomic responses through cytoplasmic and membrane signaling pathways. These mechanisms allow rapid modulation of processes such as cellular proliferation, survival, cytoskeletal dynamics and intracellular kinase activity. Within the ovary, these pathways integrate with regulation of steroidogenesis and with the response of follicular cells to gonadotropic and paracrine signals.

Rapid androgen responses help explain why their effect on folliculogenesis is not limited to slow transcriptional regulation. In certain contexts, androgen signaling can promptly influence granulosa cell sensitivity to FSH, intercellular communication and the activity of cellular growth and adaptation pathways. This broadens the temporal spectrum of androgen action and demonstrates that the system is designed to influence both genetic programming and immediate functional regulation.

From an endocrinological perspective, non genomic actions do not replace the role of the nuclear receptor, but complement it. The final effect of androgens within the follicle results from the convergence of ligand concentration, access to the androgen receptor, the coregulator profile and activation of rapid intracellular pathways. This integration is one of the reasons why small variations in androgen signaling may have significant effects on follicular competence when they occur during sensitive stages of development.

The existence of rapid pathways ultimately reinforces the concept that the ovary does not interpret androgens as simple biochemical precursors, but as fully functional signals. Their effects extend across multiple temporal and molecular levels, coordinating follicular growth, steroidogenesis and adaptation to the biological context.

Ovarian androgen physiology demonstrates that the endocrine signal results from a complex chain comprising thecal biosynthesis, diffusion within the follicular compartment, use as estrogen precursors, plasma transport, peripheral metabolism and interaction with the androgen receptor. Each step may be modulated by the phase of the cycle, LH sensitivity, granulosa cell status, metabolic balance and the characteristics of target tissues. Consequently, the biological significance of androgens does not correspond to a simple serum value.

In particular, the plasma concentration of androstenedione or testosterone does not automatically describe the quality of androgen exposure within an individual follicle. The ovary is a compartmentalized system in which local production, aromatization and receptor response may profoundly alter signaling within the follicular microenvironment. The free fraction, influenced by SHBG, may also change signal bioavailability without total levels fully reflecting the intensity of biological action.

In conclusion, ovarian androgens define an endocrine system in which stability depends on thecal production and plasma transport, while adaptability depends on the ability of the follicle to use, convert or limit the signal appropriately. Genomic action mediated by the androgen receptor accounts for their role in follicular growth, FSH sensitivity and steroidogenic competence, while non genomic pathways complete the picture through rapid responses and integration with other cellular signals. This perspective is essential for understanding normal follicular physiology, the functional significance of androgen precursors and conditions in which the balance among androgens, estrogens and gonadotropins is altered at the ovarian or systemic level.